CVS vs JNJ: Which Is the Better Dividend Stock?
As of July 2026, JNJ (Johnson & Johnson) screens as the stronger dividend stock, winning 5 of 8 head-to-head metrics. CVS offers the higher yield at 2.47%, JNJ has the higher dividend-safety score, and CVS trades at the larger discount to fair value (+18%).
| Metric | CVS | JNJ |
|---|---|---|
| Forward yield | 2.47% | 2.15% |
| Annual dividend | $2.66 | $5.36 |
| Payout ratio | 117% | 61% |
| Years of growth | 0 yr | 55 yr |
| 5-yr dividend growth | 5.9% | 5.2% |
| 5-yr total return | 24% | 46% |
| Dividend safety score | 85 (A) | 93 (A) |
| Fair value estimate | $126.39 | $229.37 |
| Upside to fair value | +18% | -9% |
| Frequency | quarterly | quarterly |
| Market cap | $141.1B | $603.3B |
| P/E ratio | 47.3 | 28.9 |
Higher yield
CVS
2.47%
Safer dividend
JNJ
Grade A
Faster growth
CVS
5.9%
Better value
CVS
+18% upside
CVS vs JNJ — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.